Scientific Letter: Ac-SDKP (N-Acetyl-Seryl-Aspartyl-Lysyl-Proline) and Galectin-3 Levels in Tuberculous Pericardial Effusion: Implications for Pathogenesis and Prevention of Pericardial Constriction

Heart - United Kingdom
doi 10.1136/heartjnl-2012-302196
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Tuberculous Pericardial Effusion

Heart
Cardiovascular MedicineCardiology
1943English

N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: A Valuable Endogenous Anti-Fibrotic Peptide for Combating Kidney Fibrosis in Diabetes

Frontiers in Pharmacology
Pharmacology
2014English

Renal and Metabolic Clearance of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (AcSDKP) During Angiotensin-Converting Enzyme Inhibition in Humans

Hypertension
Internal Medicine
1999English

Combination Treatment With N-Acetyl-Seryl-Aspartyl-Lysyl-Proline and Tissue Plasminogen Activator Provides Potent Neuroprotection in Rats After Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2014English

An Unusual Presentation of Tuberculous Pericardial Effusion

Journal of SAFOG
GynecologyObstetrics
2009English

Pericardial Constriction.

Circulation
Cardiovascular MedicinePhysiologyCardiology
1978English

Dorsal Test for Pericardial Effusion

BMJ
1897English

Hodgkin's Disease and Pericardial Effusion

Thorax
PulmonaryRespiratory Medicine
1970English

Cytokines in Pericardial Effusion of Patients With Inflammatory Pericardial Disease

Mediators of Inflammation
ImmunologyCell Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy